Cargando…

Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study

Recent reports highlighted the significant neuroprotective effects of thyronamines (TAMs), a class of endogenous thyroid hormone derivatives. In particular, 3-iodothyronamine (T1AM) has been shown to play a pleiotropic role in neurodegeneration by modulating energy metabolism and neurological functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	di Leo, Nicoletta, Moscato, Stefania, Borso’, Marco, Sestito, Simona, Polini, Beatrice, Bandini, Lavinia, Grillone, Agostina, Battaglini, Matteo, Saba, Alessandro, Mattii, Letizia, Ciofani, Gianni, Chiellini, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999687/ https://www.ncbi.nlm.nih.gov/pubmed/33799468 http://dx.doi.org/10.3390/molecules26061616

Ejemplares similares

Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
por: Grillone, Agostina, et al.
Publicado: (2019)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019)

Preparation, Characterization, and Preliminary In Vitro Testing of Nanoceria-Loaded Liposomes
por: Grillone, Agostina, et al.
Publicado: (2017)

SUN-717 SG-2 a Novel Multi-Target Directed Ligand (MTDL) for the Treatment of Neurodegenerative Diseases (NDDS)
por: Sestito, Simona, et al.
Publicado: (2020)

Effect of Combined Levothyroxine (L-T(4)) and 3-Iodothyronamine (T(1)AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
por: Rutigliano, Grazia, et al.
Publicado: (2023)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020)

ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
por: Saponaro, Federica, et al.
Publicado: (2020)

Potential role of two novel agonists of thyroid hormone receptor‐β on liver regeneration
por: Perra, Andrea, et al.
Publicado: (2020)

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders
por: Saponaro, Federica, et al.
Publicado: (2021)

Nanoparticles Based on Quaternary Ammonium Chitosan-methyl-β-cyclodextrin Conjugate for the Neuropeptide Dalargin Delivery to the Central Nervous System: An In Vitro Study
por: Migone, Chiara, et al.
Publicado: (2020)

Natural Antioxidant Compounds as Potential Pharmaceutical Tools against Neurodegenerative Diseases
por: Marino, Attilio, et al.
Publicado: (2022)

Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy
por: Ciofani, Gianni, et al.
Publicado: (2010)

Ex Vivo and in Vivo Study of Sucrosomial(®) Iron Intestinal Absorption and Bioavailability
por: Fabiano, Angela, et al.
Publicado: (2018)

Subcellular Localization of Connexin 26 in Cardiomyocytes and in Cardiomyocyte-Derived Extracellular Vesicles
por: Falleni, Alessandra, et al.
Publicado: (2021)

Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019)

Tannic Acid–Iron Complex-Based Nanoparticles as a Novel Tool against Oxidative Stress
por: Pucci, Carlotta, et al.
Publicado: (2022)

scTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells
por: Bianchi, Agostina, et al.
Publicado: (2022)

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
por: Peeters, Marlies J. W., et al.
Publicado: (2019)

Differential TAM receptor–ligand–phospholipid interactions delimit differential TAM bioactivities
por: Lew, Erin D, et al.
Publicado: (2014)

Ultrasound-Activated Piezoelectric Nanoparticles Inhibit Proliferation of Breast Cancer Cells
por: Marino, Attilio, et al.
Publicado: (2018)

Investigation of interactions between poly-l-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation
por: Ciofani, G, et al.
Publicado: (2010)

Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model
por: Madonna, Rosalinda, et al.
Publicado: (2021)

CeO(2) Nanoparticles-Loaded pH-Responsive Microparticles with Antitumoral Properties as Therapeutic Modulators for Osteosarcoma
por: Tapeinos, Christos, et al.
Publicado: (2018)

A 3D Biohybrid Real-Scale Model of the Brain Cancer Microenvironment for Advanced In Vitro Testing
por: Tricinci, Omar, et al.
Publicado: (2020)

Dysregulated insulin secretion is associated with pancreatic β‐cell hyperplasia and direct acinar‐β‐cell trans‐differentiation in partially eNOS‐deficient mice
por: Novelli, Michela, et al.
Publicado: (2022)

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
por: Polini, Beatrice, et al.
Publicado: (2023)

Diversification of TAM receptor function
por: Zagórska, Anna, et al.
Publicado: (2014)

Targeting the TAM Receptors in Leukemia
por: Huey, Madeline G., et al.
Publicado: (2016)

DICERing macrophages for reprogramming TAMs
por: Squadrito, Mario Leonardo, et al.
Publicado: (2016)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

TAM Signaling in the Nervous System
por: Burstyn-Cohen, Tal, et al.
Publicado: (2021)

Sensorization of microfluidic brain-on-a-chip devices: Towards a new generation of integrated drug screening systems
por: Marino, Attilio, et al.
Publicado: (2023)

Conserved features in TamA enable interaction with TamB to drive the activity of the translocation and assembly module
por: Selkrig, Joel, et al.
Publicado: (2015)

Magnetic self-assembly of 3D multicellular microscaffolds: A biomimetic brain tumor-on-a-chip for drug delivery and selectivity testing
por: Marino, Attilio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m3imcpo26u6f5eos0fmqknfgkh